Report Feature
The technologies in guidewire have undergone significant change in recent years, with stainless steel based guidewire to hybrid guidewire. The rising wave of new technologies such as nitinol and hybrid material technology are creating significant potential for advanced guidewire in various medical platforms due to its excellent pushability and torquability.
In guidewire market, various material technologies such as nitinol, stainless steel, and hybrid technologies are used in the coronary, peripheral, urology, neurovascular, and gastroenterology applications. Increasing target disease incidence and rising adoption of minimally invasive surgical procedures are creating new opportunities for various guidewire technologies.
Some of the latest technological developments by various countries in the guidewire market are as follows:
The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global guidewire technology by application, technology, and region as follows:
Technology Readiness by Material Technology
Competitive Intensity and Regulatory Compliance
Disruption Potential by Material Technology
Trends and Forecasts by Material Technology [$M shipment analysis from 2018 to 2030]:
Companies / Ecosystems
Strategic Opportunities by Material Technology
Some of the guidewire companies profiled in this report include Medtronic, Boston Scientific, C.R. Bard, Terumo Corporation, Abbott Laboratories, B. Braun, Johnson & Johnson, Stryker Corporation, Olympus Corporation, and Angiodynamics.
Below are the latest technological developments from top companies in the guidewire market:
Q.1 What are some of the most promising and high-growth technology opportunities for the guidewire market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in guidewire market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats to these technologies in guidewire market?
Q.6 What are the latest developments in guidewire technologies? Which companies are leading these developments?
Q.7 Which technologies have potential of disruption in this market?
Q.8 Who are the major players in this guidewire market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this guidewire technology space?
In guidewire market, various material technologies such as nitinol, stainless steel, and hybrid technologies are used in the coronary, peripheral, urology, neurovascular, and gastroenterology applications. Increasing target disease incidence and rising adoption of minimally invasive surgical procedures are creating new opportunities for various guidewire technologies.
Some of the latest technological developments by various countries in the guidewire market are as follows:
- United States: Boston Scientific, a leading medical device manufacturer, secured FDA approval for its novel nitinol-based guidewire designed specifically for peripheral vascular interventions. This signifies a significant advancement in minimally invasive treatment options for peripheral artery disease.
- China: MicroPort, a Chinese medical device company, recently announced the launch of its innovative stainless steel guidewire. This guidewire boasts enhanced flexibility, making it particularly suitable for neurovascular procedures. This development highlights China's growing contribution to the guidewire technology landscape.
- Germany: B. Braun, a German medical device company, initiated a clinical trial to assess the efficacy of its new hybrid guidewire for treating coronary artery blockages. This clinical trial underscores the ongoing efforts in refining guidewire technology to improve the treatment of coronary artery diseases.
- Japan: Terumo, a Japanese medical technology company, received CE Mark approval for its next-generation nitinol-based guidewire. This guidewire is designed for treating occluded peripheral arteries. This approval indicates Japan's focus on developing advanced guidewire solutions for improved peripheral artery disease treatment.
The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global guidewire technology by application, technology, and region as follows:
Technology Readiness by Material Technology
Competitive Intensity and Regulatory Compliance
Disruption Potential by Material Technology
Trends and Forecasts by Material Technology [$M shipment analysis from 2018 to 2030]:
- Nitinol Based Guidewire
- Stainless Steel Based Guidewire
- Hybrid Based Guidewire
-
Coronary
- Nitinol Based Guidewire
- Stainless Steel Based Guidewire
- Hybrid Based Guidewire
-
Peripheral
- Nitinol Based Guidewire
- Stainless Steel Based Guidewire
- Hybrid Based Guidewire
-
Urology
- Nitinol Based Guidewire
- Stainless Steel Based Guidewire
- Hybrid Based Guidewire
-
Neurovascular
- Nitinol Based Guidewire
- Stainless Steel Based Guidewire
- Hybrid Based Guidewire
-
Gastroenterology
- Nitinol Based Guidewire
- Stainless Steel Based Guidewire
- Hybrid Based Guidewire
- Others
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- Japan
- China
- South Korea
- India
- The Rest of the World
Companies / Ecosystems
Strategic Opportunities by Material Technology
Some of the guidewire companies profiled in this report include Medtronic, Boston Scientific, C.R. Bard, Terumo Corporation, Abbott Laboratories, B. Braun, Johnson & Johnson, Stryker Corporation, Olympus Corporation, and Angiodynamics.
Below are the latest technological developments from top companies in the guidewire market:
- Abbott announced the launch of its new generation Nitinol guidewire, the "EmboCoil Guidewire," designed for specifically for improved stability and maneuverability during embolization procedures. This launch caters to the growing demand for minimally invasive treatments in the cardiology segment.
- Boston Scientific received FDA approval for its next-generation Nitinol guidewire, the "AmigoRX." This product boasts an enhanced tip design for superior crossing power in complex vasculature, addressing a key challenge faced by surgeons.
- Terumo highlighted an increase in capital expenditure (capex) towards expanding their stainless steel guidewire production capacity. This suggests they anticipate rising demand for cost-effective guidewire options in emerging markets.
- B. Braun, a leading manufacturer of stainless steel guidewires, has been focusing on strategic partnerships with hospitals and clinics in developing regions to improve access to affordable guidewire technology.
- Teleflex announced collaboration with a research institute to develop a novel hybrid guidewire design that combines Nitinol's flexibility with the strength of stainless steel. This innovation has the potential to revolutionize guidewire technology for complex interventions.
Q.1 What are some of the most promising and high-growth technology opportunities for the guidewire market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in guidewire market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats to these technologies in guidewire market?
Q.6 What are the latest developments in guidewire technologies? Which companies are leading these developments?
Q.7 Which technologies have potential of disruption in this market?
Q.8 Who are the major players in this guidewire market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this guidewire technology space?
Table of Contents
1. Executive Summary 2. Technology Landscape 2.1. Technology Background and Evolution 2.2. Technology and Application Mapping 2.3. Supply Chain
3. Technology Readiness 3.1. Technology Commercialization and Readiness 3.2. Drivers and Challenges in Guidewire Technologies 3.3. Competitive Intensity 3.4. Regulatory Compliance
4. Technology Trends and Forecasts Analysis from 2018-2030 4.1. Guidewire Opportunity 4.2. Technology Trends (2018-2023) and Forecasts (2024-2030)
5. Technology Opportunities (2013-2024) by Region 5.1. Guidewire Market by Region 5.2. North American Guidewire Technology Market
6. Latest Developments and Innovations in the Guidewire Technologies 7. Companies / Ecosystem 7.1. Product Portfolio Analysis 7.2. Market Share Analysis 7.3. Geographical Reach
8. Strategic Implications 8.1. Implications 8.2. Growth Opportunity Analysis
9. Company Profiles of Leading Players 9.1. Medtronic 9.2. Boston Scientific 9.3. C.R. Bard 9.4. Terumo Corporation 9.5. Abbott Laboratories 9.6. B. Braun 9.7. Johnson & Johnson 9.8. Stryker Corporation 9.9. Olympus Corporation 9.10. Angiodynamics
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
